Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
CEO Lars Fruergaard Jorgensen discusses Wegovy
It’s been a rocky few months for Novo Nordisk. Prescription data from IQVIA suggests Novo’s obesity drug Wegovy is losing ground to rival Zepbound from